A new eye implant, ENCELTO, may help slow vision loss in people with macular telangiectasia type 2 (MacTel), a rare retinal disorder. A study published in NEJM Evidence showed the implant reduced retinal damage by up to 54.8%, offering a potential treatment option for a condition with no approved therapies.